1-6 of 6
James Robinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1/2 Study of a ROR1-Targeting CAR T Cell Therapy (ONCT-808) in Adult Patients with Relapsed/Refractory (R/R) Aggressive B Cell Lymphomas (BCL)

Michael Wang, Patrick Connor Johnson, Salim Yazji, Yisrael Katz, Angela Pietrofeso, James Robinson, Matthew Mei, Matthew J. Frigault, James B. Breitmeyer, Caron A. Jacobson
Journal: Blood
Blood (2024) 144 (Supplement 1): 1743.
https://doi.org/10.1182/blood-2024-200998
Published: 2024
Journal Articles

Trial-in-Progress: A Phase 1/2 Multi-Center Study of Onct-808, a ROR1-Specific CAR T, in Adult Patients with Relapsed/Refractory Aggressive B Cell Lymphoma

Michael L. Wang, Matthew J. Frigault, Salim Yazji, Yisrael Katz, James Robinson, James B. Breitmeyer, Matthew G. Mei, Caron A Jacobson
Journal: Blood
Blood (2023) 142 (Supplement 1): 4857.
https://doi.org/10.1182/blood-2023-180989
Published: 2023
Journal Articles

COVID-19 Immune Response in Hematologic Malignancies: Analysis of COVID-19 Anti-Spike Antibodies in Previously Infected and Uninfected Patients

Alex Niu, Victor H Ramirez, Bronwyn Gunn, Melyssa Bratton, Sarah Foster, James Robinson, Sree Lanka, Hana Safah, Francisco Socola, Yunwen Huang, Crystal Y Zheng, Ivy V Trinh, Amelie E Murrell, Jeffrey G Shaffer, Elizabeth B Norton, Nakhle S. Saba
Journal: Blood
Blood (2022) 140 (Supplement 1): 8351–8353.
https://doi.org/10.1182/blood-2022-165019
Published: 2022
Journal Articles

Diverse Drug Combinations with an Eed Inhibitor Confer Context-Specific Benefit across Multiple Tumor Types

Jessie Hao-Ru Hsu, Sasha Borodovsky, Yanjun Wang, Maryann San Martin, Minhui Shen, Haley Woods, Alan Rosen, Sharan Bagal, Philip Rawlins, James Robinson, Erin Code, Laura Prickett, Andrew Bloecher
Journal: Blood
Blood (2021) 138 (Supplement 1): 2274.
https://doi.org/10.1182/blood-2021-150483
Published: 2021
Journal Articles

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Bronwen E. Shaw, PhD MRCP, FRCPath, Brent R. Logan, PhD, Stephen R. Spellman, Steven GE Marsh, BSc, PhD ARCS, James Robinson, BSc, MSc, Joseph Pidala, MD PhD, Carolyn Hurley, PhD, Juliet Barker, MBBS, Martin Maiers, PhD, Jason Dehn, MPH, Hailin Wang, MPH, Michael Haagenson, MS, David L Porter, MD, Effie W. Petersdorf, MD, Ann Woolfrey, MD, Mary M. Horowitz, MD MS, Michael R Verneris, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, MD, Stephanie J Lee, MD MPH
Journal: Blood
Blood (2017) 130 (Supplement 1): 848.
https://doi.org/10.1182/blood.V130.Suppl_1.848.848
Published: 2017
Journal Articles

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Joseph Pidala, Stephanie J. Lee, Kwang Woo Ahn, Stephen Spellman, Hai-Lin Wang, Mahmoud Aljurf, Medhat Askar, Jason Dehn, Marcelo Fernandez Viña, Alois Gratwohl, Vikas Gupta, Rabi Hanna, Mary M. Horowitz, Carolyn K. Hurley, Yoshihiro Inamoto, Adetola A. Kassim, Taiga Nishihori, Carlheinz Mueller, Machteld Oudshoorn, Effie W. Petersdorf, Vinod Prasad, James Robinson, Wael Saber, Kirk R. Schultz, Bronwen Shaw, Jan Storek, William A. Wood, Ann E. Woolfrey, Claudio Anasetti
Journal: Blood
Blood (2014) 124 (16): 2596–2606.
https://doi.org/10.1182/blood-2014-05-576041
Published: 2014